Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies
Optimizing Manufacturing Processes to Enable Stable Production of High-Quality ADCs August 3, 2026 — FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and Taiho Pharmaceutical Co., Ltd. (President and Representative Director: Masayuki Kobayashi) today… Read More »Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies





